After legal battles and lobbying efforts, tens of thousands of people with hepatitis C are gaining earlier access to expensive drugs that can cure this condition.
States that limited access to the medications out of concern over sky-high prices have begun to lift those restrictions — many, under the threat of legal action. And commercial insurers such as Anthem Inc. and United …
(continue reading)
Article source: https://health.einnews.com/article_detail/334086366/t2FdI6xPBTiZytK9?ref=rss&ecode=uiQ1mLaH2KVPSS4e